Marvell's FY2028 Potential Spotlighted as Market Shifts Forward, But Execution Risk Remains

What happened

The Seeking Alpha article argues that Marvell is evolving into a dual business of high-margin connectivity and fast-growing custom silicon for hyperscalers, and that the market is no longer trading on FY2027 but on FY2028 estimates, making the stock compelling on a forward basis. This builds on Marvell's Q1 FY27 results of $2.418B revenue (up 28% YoY) with data center at 76% of sales, driven by AI demand across electro-optics, custom, storage, and switching, and management's guidance for Q2 FY27 at $2.7B ±5%. However, the stock trades at 75.4x P/E and 43.1x EV/EBITDA after a 172% rise from July 2025, and the master report rated MRVL a WAIT, citing that current price already discounts sustained hyperscaler spending and clean execution. The article acknowledges that custom silicon growth drives revenue but may compress gross margins, while merchant networking remains a high-quality margin anchor, suggesting a more complex margin trajectory ahead. The next catalysts remain the quarterly print versus guidance, continued breadth of AI demand across product lines, and progress of the 102.4T Teralynx switch beyond sampling.

Implication

The article's shift to FY2028 estimates implies that any hiccup in custom silicon ramp or gross margin compression could lead to significant multiple compression. With no margin of safety at current prices, position sizing should be conservative, and entry points near the master report's attractive entry of $185 would offer a better risk/reward. Monitoring signs of AI demand broadening across all four product layers and progress on the 102.4T switch are essential to validate the forward narrative. The dual-business structure may provide some resilience, but the high customer concentration (top 10 customers at 82% of FY26 revenue) amplifies execution risk. Until filings confirm that custom silicon revenue is scaling without disproportionately hurting margins, the WAIT rating remains appropriate, and investors should wait for a pullback or a clear conversion signal.

Thesis delta

The article's argument that the market is no longer trading on FY2027 introduces a potential shift in valuation framework, but it does not alter the core risk-reward calculation without new execution evidence. The master report's WAIT rating remains supported, as the stock still trades at elevated multiples and depends on on-time custom silicon conversion. The next two quarterly filings will be critical to determine whether the market's forward-looking optimism is justified.